Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

The Lancet Infectious Diseases - Tập 10 Số 9 - Trang 597-602 - 2010
Karthikeyan Kumarasamy1, Antoine Andremont2, Timothy R. Walsh2, Jay Bagaria3, Fafhana Butt4, Ravi Balakrishnan3, Uma Chaudhary5, Michel Doumith3, Christian G. Giske6, Seema Irfan7, Padma Krishnan1, Anil Kumar8, Sunil Maharjan3, Shazad Mushtaq3, Tabassum Noorie3, David L. Paterson9, A Pearson3, Claire Perry3, Rachel Pike3, Bhargavi Rao3, Ujjwayini Ray10, Jayanta Sarma11, Madhu Sharma5, Elizabeth Sheridan3, M.A. Thirunarayan12, Jane F. Turton3, Supriya Upadhyay13, Marina Warner3, William Welfare3, David M. Livermore3, Neil Woodford3
1Department of Microbiology, Dr. ALM PG IBMS, University of Madras, Chennai, India
2Department of Infection, Immunity and Biochemistry, School of Medicine, Cardiff University, Cardiff, UK
3Health Protection Agency Centre for Infections, London, UK
4Department of Microbiology, Shaukat Khanum Cancer Hospital, Lahore, Pakistan
5Department of Microbiology, Pandit B D Sharma PG Institute of Medical Sciences, Haryana, India
6Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
7Department of Pathology and Microbiology, The Aga Khan University, Karachi, Pakistan
8Department of Microbiology, Amrita Institute of Medical Sciences, Kerala, India
9University of Queensland Centre for Clinical Research, University of Brisbane, Herston, QLD, Australia
10Department of Microbiology, Apollo Gleneagles Hospital, Kolkata, India
11Department of Medical Microbiology, Northumbria Healthcare NHS Foundation Trust, Tyne and Wear, UK
12Department of Microbiology, Apollo Hospitals, Chennai, India
13Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

Tóm tắt

Từ khóa


Tài liệu tham khảo

Cornaglia, 2009, Fighting infections due to multidrug-resistant Gram-positive pathogens, Clin Microbiol Infect, 15, 209, 10.1111/j.1469-0691.2009.02737.x

Tan, 2008, “Future” threat of Gram-negative resistance in Singapore, Ann Acad Med Singapore, 37, 884, 10.47102/annals-acadmedsg.V37N10p884

Baiden, 2010, The need for new antibiotics, Lancet, 375, 637, 10.1016/S0140-6736(10)60265-6

Heddini, 2009, Antibiotic resistance in China—a major future challenge, Lancet, 373, 30, 10.1016/S0140-6736(08)61956-X

Vento, 2010, The need for new antibiotics, Lancet, 375, 637, 10.1016/S0140-6736(10)60264-4

Wise, 2010, The need for new antibiotics, Lancet, 375, 638, 10.1016/S0140-6736(10)60266-8

Boucher, 2009, Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America, Clin Infect Dis, 48, 1, 10.1086/595011

Rice, 2009, The clinical consequences of antimicrobial resistance, Curr Opin Microbiol, 12, 476, 10.1016/j.mib.2009.08.001

Page, 2009, Prospects for the next anti-pseudomonas drug, Curr Opin Pharmacol, 9, 558, 10.1016/j.coph.2009.08.006

Carattoli, 2009, Resistance plasmid families in Enterobacteriaceae, Antimicrob Agents Chemother, 53, 2227, 10.1128/AAC.01707-08

Carattoli, 2006, Replicon typing of plasmids encoding resistance to newer beta-lactams, Emerg Infect Dis, 12, 1145, 10.3201/eid1207.051555

Walsh, 2006, Combinatorial genetic evolution of multiresistance, Curr Opin Microbiol, 9, 476, 10.1016/j.mib.2006.08.009

Hawkey, 2009, The changing epidemiology of resistance, J Antimicrob Chemother, 64, i3, 10.1093/jac/dkp256

Walsh, 2007, Comment on: occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals, J Antimicrob Chemother, 59, 799, 10.1093/jac/dkl532

Hawkey, 2008, Prevalence and clonality of extended-spectrum beta-lactamases in Asia, Clin Microbiol Infect, 14, 159, 10.1111/j.1469-0691.2007.01855.x

Lartigue, 2006, In vitro analysis of ISEcp1B-mediated mobilization of naturally occurring β-lactamase gene blaCTX-M of Kluyvera ascorbata, Antimicrob Agents Chemother, 50, 1282, 10.1128/AAC.50.4.1282-1286.2006

Canton, 2006, The CTX-M beta-lactamase pandemic, Curr Opin Microbiol, 9, 466, 10.1016/j.mib.2006.08.011

Livermore, 2007, CTX-M: changing the face of ESBLs in Europe, J Antimicrob Chemother, 59, 165, 10.1093/jac/dkl483

Harish, 2007, Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from blood culture, J Med Microbiol, 56, 999, 10.1099/jmm.0.47072-0

Livermore, 2009, Has the era of untreatable infections arrived?, J Antimicrob Chemother, 64, i29, 10.1093/jac/dkp255

Nordmann, 2009, The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria, Lancet Infect Dis, 9, 228, 10.1016/S1473-3099(09)70054-4

Yong, 2009, Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India, Antimicrob Agents Chemother, 53, 5046, 10.1128/AAC.00774-09

Anderson, 2007, Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae, J Clin Microbiol, 45, 2723, 10.1128/JCM.00015-07

Souli, 2006, In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, Gram-negative and Gram-positive clinical isolates from Greek hospitals, Antimicrob Agents Chemother, 50, 3166, 10.1128/AAC.00322-06

Antoniadou, 2007, Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster, J Antimicrob Chemother, 59, 786, 10.1093/jac/dkl562

Ghafur, 2010, An obituary—on the death of antibiotics!, J Assoc Physician India, 58, 143

Shahid, 2009, Comparison of beta-lactamase genes in clinical and food bacterial isolates in India, J Infect Dev Ctries, 3, 593, 10.3855/jidc.550

2009

Lakhani

Thông tin
Thông tin xuất bản

The Lancet Infectious Diseases

Tập 10 Số 9

597-602

Thông tin tác giả